We're approaching the end of 2025, which also marks the conclusion of the third year of the new wave of generative AI. At the end of 2024, we thought we had a handle on how much AI would change us, ...
The Swedish company is now valued at $6.6 billion, more than triple its $1.8 billion valuation set by investors in July.
At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for ...
Lovable has seen its valuation more than triple just five months after the company's last funding round in July.